MFA Financial Inc. Stock Remains Steady Thursday, Still Outperforms Market

Neuropace Inc

Change company Symbol lookup

Select an option...

NPCE Neuropace Inc

CLM Cornerstone Strategic Value Fund

RCI Rogers Communications Inc

ADRA Adara Acquisition Corp

EVTC Evertec Inc

OPEN Opendoor Technologies Inc

XAIR Beyond Air Inc

SHEL Shell PLC

CXE MFS High Income Municipal Trust

CWGL Crimson Wine Group Ltd

Health Care : Health Care Equipment & Supplies | Small Cap Value

Company profile

NeuroPace, Inc. is a commercial-stage medical device company. The Company is focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company’s novel and differentiated RNS System is the brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source. The Company’s RNS System is a platform that delivers care for patients suffering from drug-resistant epilepsy and offers a personalized solution and outcomes to the patients suffering from other brain disorders. RNS System is a device that records brain activity data and clinicians to monitor patients. RNS System monitors the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is engaged in treating other brain disorders including depression, impulse control disorders, memory disorders, and post-traumatic stress.

MFA Financial Inc. Stock Remains Steady Thursday, Still Outperforms Market

5:07 pm ET March 3, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of MFA Financial Inc. (MFA) were unchanged Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.56% to 13,537.94 and Dow Jones Industrial Average falling 0.29% to 33,794.66. MFA Financial Inc. closed $0.84 below its 52-week high ($4.90), which the company reached on June 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as PennyMac Mortgage Investment Trust (PMT) fell 0.31% to $15.85 and Invesco Mortgage Capital Inc. (IVR) rose 0.47% to $2.14. Trading volume (2.2 M) remained 1.8 million below its 50-day average volume of 4.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

March 03, 2022 17:07 ET (22:07 GMT)

Postmarket

Change Since Close

Market Hours

MFA Financial Inc. Stock Remains Steady Thursday, Still Outperforms Market